Summit Therapeutics Inc (SMMT)

Apr 26, 2026

SMMT stock up 24% in three months: Here's what you need to know - MSN

Apr 26, 2026

Apr 25, 2026

Trading Systems Reacting to (SMMT) Volatility - Stock Traders Daily

Apr 25, 2026

Apr 25, 2026

Summit Therapeutics PLC (NASDAQ:SMMT) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Apr 25, 2026

Apr 23, 2026

Summit Therapeutics shows rising price performance with jump to 82 RS rating - MSN

Apr 23, 2026

Apr 22, 2026

Summit Therapeutics (NASDAQ:SMMT) Shares Down 6.2%Time to Sell? - MarketBeat

Apr 22, 2026

Apr 22, 2026

Investors Buy Large Volume of Call Options on Summit Therapeutics (NASDAQ:SMMT) - MarketBeat

Apr 22, 2026

Apr 21, 2026

SMMT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Apr 21, 2026

Apr 21, 2026

Summit Therapeutics (SMMT) jumps as investors refocus on upcoming ivonescimab data and bullish recent coverage - Quiver Quantitative

Apr 21, 2026

Apr 21, 2026

Positive Outlook for Summit Therapeutics (SMMT) Following ASCO P - GuruFocus

Apr 21, 2026

Apr 21, 2026

Summit Therapeutics (NASDAQ:SMMT) Sees Strong Trading VolumeHere's Why - MarketBeat

Apr 21, 2026

Apr 21, 2026

Stifel reiterates Summit Therapeutics stock rating on trial data By Investing.com - Investing.com Canada

Apr 21, 2026

Apr 21, 2026

Summit partner selection for ASCO ‘likely a major positive,’ says Guggenheim - TipRanks

Apr 21, 2026

Apr 21, 2026

Guggenheim Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Maintains Target Price $40 - Moomoo

Apr 21, 2026

Apr 20, 2026

Summit Therapeutics Inc. (SMMT): Investor Outlook on This Biotech Stock with 23.70% Potential Upside - DirectorsTalk Interviews

Apr 20, 2026

Apr 20, 2026

SMMT Technical Analysis | Trend, Signals & Chart Patterns | SUMMIT THERAPEUTICS INC (NASDAQ:SMMT) - ChartMill

Apr 20, 2026

Apr 19, 2026

IonQ, Oklo, And Robinhood Are Among the Top 10 Large-Cap Gainers Last Week (April 13-April 17): Are the Others in Your Portfolio? - Benzinga

Apr 19, 2026

Apr 17, 2026

Board seats, pay and equity plan on ballot at Summit Therapeutics (NASDAQ: SMMT) - Stock Titan

Apr 17, 2026

Apr 17, 2026

UBS reiterates Buy on Summit Therapeutics stock ahead of trial data - Investing.com Canada

Apr 17, 2026

Apr 17, 2026

Evercore Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Maintains Target Price $34 - Moomoo

Apr 17, 2026

Apr 17, 2026

Summit Therapeutics has scarcity value in a crowded drug race: Analyst - MSN

Apr 17, 2026

Apr 16, 2026

Summit Therapeutics Inc Stock (SMMT) Moved Up by 12.03% on Apr 16: Drivers Behind the Movement - TradingKey

Apr 16, 2026

Apr 16, 2026

Summit Therapeutics (NASDAQ:SMMT) Stock Price Up 8.2%Still a Buy? - MarketBeat

Apr 16, 2026

Apr 16, 2026

SMMT Stock Up 24% in Three Months: Here's What You Need to Know - Yahoo Finance

Apr 16, 2026

Apr 16, 2026

Been holding for so long - Moomoo

Apr 16, 2026

Apr 14, 2026

Summit Therapeutics Stock Slumps After Partner Akeso Gets FDA Nod For Cancer Drug: Retail’s Optimistic - MSN

Apr 14, 2026

Apr 14, 2026

How Summit Therapeutics Inc. (SMMT) Affects Rotational Strategy Timing - Stock Traders Daily

Apr 14, 2026

Apr 12, 2026

What makes Summit Therapeutics (SMMT) one of the best large caps under $30 - MSN

Apr 12, 2026

Apr 12, 2026

Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2025 - ADVFN

Apr 12, 2026

Apr 10, 2026

Aug PostEarnings: Can Summit Therapeutics Inc be the next market leader2026 Investor Takeaways & Growth Focused Entry Point Reports - baoquankhu1.vn

Apr 10, 2026

Apr 10, 2026

SMMT News | SUMMIT THERAPEUTICS INC (NASDAQ:SMMT) - ChartMill

Apr 10, 2026

Apr 09, 2026

Inflation Data: Can Summit Therapeutics Inc stock outperform in a bear marketBreakout Watch & Stock Portfolio Risk Control - baoquankhu1.vn

Apr 09, 2026

Apr 09, 2026

SMMT Analyst Rating: Citigroup Initiates Buy Coverage April 2026 - Meyka

Apr 09, 2026

Apr 09, 2026

Stifel initiates coverage of Summit Therapeutics (SMMT) with buy recommendation - MSN

Apr 09, 2026

Apr 09, 2026

This Inhibrx Biosciences Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday - Sahm

Apr 09, 2026

Apr 09, 2026

Summit Therapeutics Has Scarcity Value In A Crowded Drug Race: Analyst - Sahm

Apr 09, 2026

Apr 09, 2026

SMMT Upgraded to Buy by Citigroup on April 08, 2026 - Meyka

Apr 09, 2026

Apr 09, 2026

Revolution Medicines and Summit Therapeutics Advance Broad RAS(ON) Combo Study in Solid Tumors - TipRanks

Apr 09, 2026

Apr 08, 2026

SMMT : POTENTIAL BOUNCEBACK Click Through The Up Coming Page (2dUA4zfHbg) - Mshale

Apr 08, 2026

Apr 08, 2026

SUMMIT THERAPEUTICS INC BIG TRADING SWING | SMMT STOCK Simply Click The Next Internet Page (JHLdCFn8fQ) - Mshale

Apr 08, 2026

Apr 08, 2026

Citigroup starts coverage of Summit Therapeutics Inc (SMMT), Apr 08 2026, Buy - Meyka

Apr 08, 2026

Apr 08, 2026

What's Going On With Summit Therapeutics Stock Wednesday?Summit Therapeutics (NASDAQ:SMMT) - Benzinga

Apr 08, 2026

Apr 08, 2026

$Summit Therapeutics (SMMT.US)$ - Moomoo

Apr 08, 2026

Apr 08, 2026

Stifel Initiates Coverage on Summit Therapeutics (SMMT) with 'Bu - GuruFocus

Apr 08, 2026

Apr 08, 2026

Pullback Watch: Is Summit Therapeutics Inc forming higher highs and higher lowsQuarterly Portfolio Review & Low Drawdown Investment Ideas - baoquankhu1.vn

Apr 08, 2026

Apr 08, 2026

Summit Therapeutics (NASDAQ:SMMT) Now Covered by Analysts at Stifel Nicolaus - MarketBeat

Apr 08, 2026

Apr 08, 2026

Tudor Investment Corp ET AL Takes $7.17 Million Position in Summit Therapeutics PLC $SMMT - MarketBeat

Apr 08, 2026

Apr 08, 2026

Stifel Initiates Coverage on Summit Therapeutics (SMMT) with 'Buy' Rating | SMMT Stock News - GuruFocus

Apr 08, 2026

Apr 08, 2026

Stifel Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Maintains Target Price $45 - Moomoo

Apr 08, 2026

Apr 08, 2026

Aug Selloffs: Is Summit Therapeutics Inc impacted by rising ratesQuarterly Market Review & High Accuracy Swing Trade Signals - baoquankhu1.vn

Apr 08, 2026

Apr 07, 2026

Stifel initiates Summit Therapeutics stock with buy rating By Investing.com - Investing.com Canada

Apr 07, 2026

Apr 07, 2026

Stifel Initiates Summit Therapeutics(SMMT.US) With Buy Rating, Announces Target Price $45 - Moomoo

Apr 07, 2026

Apr 07, 2026

Sentiment Recap: Does Summit Therapeutics Inc have a sustainable dividendInsider Buying & Expert Curated Trade Ideas - baoquankhu1.vn

Apr 07, 2026

Apr 07, 2026

Summit Therapeutics Inc. (SMMT) Highlights Ivonescimab Progress at WCLC 2025 - MSN

Apr 07, 2026